Micafungin 50/100 Sandoz 50 mg, 100 mg Powder for Concentrate for Solution for Infusion

Micafungin 50/100 Sandoz 50 mg, 100 mg Powder for Concentrate for Solution for Infusion

S4
PDF Leaflet Revision Date: 13 June 2023

API: Micafungin Sodium | Company: Sandoz Sa

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment and prophylaxis of invasive candidiasis.

Dosage (summary)

100 mg/day for adults >40 kg; 2 mg/kg/day for adults u226440 kg.

Special Populations

  • Hepatic impairment
  • Renal impairment

Pregnancy & Breastfeeding

Not recommended during pregnancy or breastfeeding.

Key Drug Interactions

  • Amphotericin B
  • Sirolimus
  • Nifedipine
  • Itraconazole

Contraindications

  • Hypersensitivity to micafungin

Common side effects

  • Nausea
  • Vomiting
  • Phlebitis
  • Increased liver enzymes

Counselling Points

  • Monitor for liver function
  • Report any rash or allergic reactions
  • Avoid in pregnancy and breastfeeding

Serious warnings

  • Risk of liver tumors
  • Anaphylactic reactions
  • Severe hepatic dysfunction
Important Disclaimer

The Micafungin 50/100 Sandoz 50 mg, 100 mg Powder for Concentrate for Solution for Infusion professional information leaflet below is the property of Sandoz Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites